Cannabis-focused research and development company The Green
Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today announced that its
joint venture (“JV”) production partner, Knud Jepsen, has received an initial
cannabis business authorization from the Danish Medicines Agency, the
government body responsible for issuing cannabis related licenses. According to
the update, the license will allow Kund Jepsen to begin immediate importation
of starting materials and research and development related to the creation of
elite cannabis genetics. Under the terms of the completed definitive agreement,
Knud Jepsen will submit a request to the Danish Medicines Agency for the
assignment of this license to the TGOD-Knud Jepsen Danish joint venture, which
is underway with expected completion in the coming weeks. The initial license
will enable importation of starting materials, the receipt, possession,
cultivation and processing of cannabis, and analytical sample distribution and
export to foreign labs. Upon cultivation and harvest of three confirmed and
consistent crops, an additional authorization license will be granted to allow
for the sale of authorized medicinal cannabis products. “Knud Jepsen is a
proven leader with a track record of excellence in genetic discoveries, R&D
and large-scale cultivation,” The Green Organic Dutchman Holdings Director and
CEO Brian Athaide stated in the news release. “TGOD is working with Health
Canada to export starting materials from Canada into Denmark and we look
forward to accelerating our expansion throughout Europe.”
To view the full press release, visit http://ibn.fm/hl4uj
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. is a publicly
traded, premium global organic cannabis company, with operations focused on
medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as
well as the Canadian adult-use market. The company grows high quality, organic
cannabis with sustainable, all-natural principles. TGOD’s products are
laboratory tested to ensure patients have access to a standardized, safe and
consistent product. TGOD has a funded capacity of 170,000kgs and is building
1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.
For more information, visit the company’s website at www.TGOD.ca
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
